Pegcyte

Pegcyte · Nanogen Pharmaceutical Biotechnology Joint Stock Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegcyte, covering 2018-01-02 to 2018-01-02. Get the full timeline:

Most recent: Clinical Trial Update: Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients. [Phase 3]